Zimulti
rimonabant
Treatment for ObesityRimonabant USA: Update
PARIS, February 12 2007 -- Sanofi-aventis announced today that the review period of rimonabant in the United State has been extended by three months, until July 27, 2007.
The Group also announced the submission of the SERENADE clinical study report today in the rimonabant NDA submitted to the FDA.
Rimonabant is a first- in-class cannabinoid type 1 receptor discovered and developed by sanofi- aventis.
SERENADE (Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients) is a multi-centre, randomized, double-blind, placebo-controlled, parallel-group study comparing rimonabant 20 mg once daily to placebo in improving blood sugar control in treatment-naive type 2 diabetic patients not adequately controlled by diet alone for a period of six months.
Source: sanofi-aventis
Related Articles:
Sanofi-aventis to Discontinue all Clinical Trials with rimonabant - November 6, 2008
Rimonabant - Regulatory Update in Europe - November 14, 2007
Committee for Medicinal Products for Human Use Post-authorisation Summary of Positive Opinion for Acomplia/Zimulti - July 19, 2007
Rimonabant Regulatory Update in the United States - June 29, 2007
Weight Loss Drug Rimonabant Can Cause Serious Physical and Psychological Harm and Birth Defects, Public Citizen Tells FDA - June 14, 2007
FDA Advisory Committee Did Not Recommend Approval of Rimonabant (Zimulti) for Use in Obese and Overweight Patients With Associated Risks Factors - June 13, 2007
Rimonabant USA: Update - March 26, 2007
Sanofi-aventis Acknowledges FDA Announcement of an Advisory Committee Meeting for rimonabant - March 26, 2007
Rimonabant Update in the United States - December 8, 2006
Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for Smoking Cessation - February 17, 2006
Rimonabant Accepted for Filing By the FDA - June 23, 2005
New Drug Applications Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
